Henry O. Gosebruch, EVP, Chief Strategy Officer at AbbVie Inc. (ABBV), sold 83,960 shares at $155.00 ($13.0M) on 2022-05-16, disclosed to the SEC on 2022-05-20.
Open-market sale of $13.0M ABBV by EVP, Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ABBV | SELL | 2022-03-02 | $6.8M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $2.2M | — | Filing → |
| ABBV | SELL | 2020-11-24 | $4.0M | — | Filing → |